Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124414872 | 12441487 | 2 | F | 2015 | 20160705 | 20160607 | 20160707 | EXP | US-PFIZER INC-2016271282 | PFIZER | 63.00 | YR | F | Y | 0.00000 | 20160707 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124414872 | 12441487 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, DAILY | Y | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | ||||||
| 124414872 | 12441487 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, ALTERNATE DAY (2-3 WKS) | Y | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | QOD | |||||
| 124414872 | 12441487 | 3 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 37.5 MG, ALTERNATE DAY (3 WKS) | Y | 20699 | 37.5 | MG | PROLONGED-RELEASE CAPSULE | QOD | |||||
| 124414872 | 12441487 | 4 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 30 MG, ALTERNATE DAY (1 WK) | Y | 20699 | 30 | MG | PROLONGED-RELEASE CAPSULE | QOD | |||||
| 124414872 | 12441487 | 5 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 25 MG, ALTERNATE DAY (1 WK) | Y | 20699 | 25 | MG | PROLONGED-RELEASE CAPSULE | QOD | |||||
| 124414872 | 12441487 | 6 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 20 MG, ALTERNATE DAY (3 WKS) | Y | 20699 | 20 | MG | PROLONGED-RELEASE CAPSULE | QOD | |||||
| 124414872 | 12441487 | 7 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 15 MG, ALTERNATE DAY (2 DOSES) | Y | 20699 | 15 | MG | PROLONGED-RELEASE CAPSULE | QOD | |||||
| 124414872 | 12441487 | 8 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 10 MG, ALTERNATE DAY (3 DOSES) | Y | 20699 | 10 | MG | PROLONGED-RELEASE CAPSULE | QOD | |||||
| 124414872 | 12441487 | 9 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 5 MG, UNK (2 DOSES) | Y | 20699 | 5 | MG | PROLONGED-RELEASE CAPSULE | ||||||
| 124414872 | 12441487 | 10 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | 50 MG, 2X/DAY | 0 | 50 | MG | BID | ||||||||
| 124414872 | 12441487 | 11 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | 50 MG, DAILY | 0 | 50 | MG | |||||||||
| 124414872 | 12441487 | 12 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 100 UG, DAILY | 0 | 100 | UG | |||||||||
| 124414872 | 12441487 | 13 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 40 MG, DAILY | 0 | 40 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124414872 | 12441487 | 1 | Depression |
| 124414872 | 12441487 | 2 | Anxiety |
| 124414872 | 12441487 | 10 | Supraventricular tachycardia |
| 124414872 | 12441487 | 12 | Thyroid disorder |
| 124414872 | 12441487 | 13 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124414872 | 12441487 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124414872 | 12441487 | Abdominal pain upper | |
| 124414872 | 12441487 | Auditory disorder | |
| 124414872 | 12441487 | Dizziness | |
| 124414872 | 12441487 | Drug intolerance | |
| 124414872 | 12441487 | Feeling abnormal | |
| 124414872 | 12441487 | Heart rate irregular | |
| 124414872 | 12441487 | Memory impairment | |
| 124414872 | 12441487 | Nausea | |
| 124414872 | 12441487 | Nystagmus | |
| 124414872 | 12441487 | Paraesthesia | |
| 124414872 | 12441487 | Tinnitus | |
| 124414872 | 12441487 | Vomiting | |
| 124414872 | 12441487 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124414872 | 12441487 | 1 | 201307 | 201603 | 0 | |
| 124414872 | 12441487 | 2 | 201603 | 2016 | 0 | |
| 124414872 | 12441487 | 3 | 2016 | 2016 | 0 | |
| 124414872 | 12441487 | 4 | 2016 | 2016 | 0 | |
| 124414872 | 12441487 | 5 | 2016 | 2016 | 0 | |
| 124414872 | 12441487 | 6 | 2016 | 2016 | 0 | |
| 124414872 | 12441487 | 7 | 2016 | 2016 | 0 | |
| 124414872 | 12441487 | 8 | 2016 | 2016 | 0 | |
| 124414872 | 12441487 | 9 | 2016 | 201605 | 0 | |
| 124414872 | 12441487 | 10 | 1981 | 0 |